
TNXP
Tonix Pharmaceuticals Holding Corp.
Company Overview
Mkt Cap | $163.22M | Price | $19.89 |
Volume | 533.44K | Change | +0.25% |
P/E Ratio | -1.3 | Open | $19.84 |
Revenue | $10.1M | Prev Close | $19.84 |
Net Income | $-130.0M | 52W Range | $6.76 - $130.00 |
Div Yield | N/A | Target | $69.00 |
Overall | 41 | Value | 80 |
Quality | 36 | Technical | 9 |
No chart data available
Stock Overview
Updated DailyTonix Pharmaceuticals Holding Corp. (TNXP) is a leading Healthcare company in the Biotechnology industry, currently trading at $19.89 with a market capitalization of $163.22 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 36.
Today's trading session shows TNXP with a volume of 533K shares. The stock opened down 0.00% from yesterday's close of $19.84. Current analyst estimates project earnings of $-14.48 per share for this year, with next year targeting $-8.61.
TNXP demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including AERI, EGRX, CYTR, UTHR.
Key investment considerations for TNXP include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 246.9%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on October 22, 2025 at 12:19 AM
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | TNXP | $19.89 | +0.3% | 533.44K |
3 | ||||
4 | ||||
5 | ||||
6 |
Get Tonix Pharmaceuticals Holding Corp. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW